Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Revenues:
Obstructive sleep apnea (OSA)	$ 68,173	$ 99,083	$ 226,549	$ 449,650
Total revenues	68,173	99,083	226,549	449,650
Costs and expenses:
Costs of revenues	2,394	46,028	110,211	280,372
General and administrative	428,077	409,419	1,269,920	1,396,478
Depreciation and amortization	84	149	524	449
Total costs and expenses	430,555	455,596	1,380,655	1,677,299
Loss from operations	(362,382)	(356,513)	(1,154,106)	(1,227,649)
Other income (expense):
Interest expense	(383,798)	(307,922)	(1,052,991)	(1,148,795)
Interest income	29		6,023
Legal settlement			112,172	328,269
State tax penalty	(1,650)		(1,650)
Extinguishment of loan due to shareholder				7,771,140
Settlement of prior accounting services				(240,000)
Other income				2,380
Total other income (expense)	(385,419)	(307,922)	(936,446)	6,712,994
Income taxes
Net (loss) income	$ (747,801)	$ (664,435)	$ (2,090,552)	$ 5,485,345
PER SHARE INFORMATION
Net (Loss) Income Per Common Share	$ (0.01)	$ (0.01)	$ (0.03)	$ 0.08
Weighted Average Number of Common Shares Outstanding	67,361,656	66,661,656	67,140,411	65,849,175